Log In
Print
BCIQ
Print
Print this Print this
 

hydrocodone bitartrate/chlorpheniramine maleate (Vituz)

  Manage Alerts
Collapse Summary General Information
Company Pernix Therapeutics Holdings Inc.
DescriptionOral combination of hydrocodone bitartrate, an antitussive, and chlorpheniramine maleate, a histamine H1 receptor (HRH1) antagonist
Molecular Target Histamine H1 receptor (HRH1)
Mechanism of ActionHistamine H1 receptor antagonist
Therapeutic Modality 
Latest Stage of DevelopmentApproved
Standard IndicationCough
Indication DetailsTreat cough and symptoms associated with upper respiratory allergies or common cold
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today